IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.
about
Severe infectious diseases of childhood as monogenic inborn errors of immunityInterleukin 17-Mediated Host Defense against Candida albicans'"Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infectionThe influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy.Immunity against fungi.Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.RORγ antagonists and inverse agonists: a patent review.Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way StreetWhen the Fight against Fungi Goes WrongA Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.Neuroimmune regulation during intestinal development and homeostasis.Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome.Identification of novel HIV-1 dependency factors in primary CCR4(+)CCR6(+)Th17 cells via a genome-wide transcriptional approach.Immunomodulation and Disease Tolerance to Staphylococcus aureusA genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.Signal transducer and activator of transcription 3: a year in review.IL-12 drives functional plasticity of human group 2 innate lymphoid cells.Pan-cancer analyses of the nuclear receptor superfamilySkin Immunity to Candida albicans.Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis.NKp80 Defines a Critical Step during Human Natural Killer Cell Development.Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets.Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery.Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations.IL-1β, But Not Programed Death-1 and Programed Death Ligand Pathway, Is Critical for the Human Th17 Response to Mycobacterium tuberculosis.Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization.Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency.Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity.Age-Dependent Association of TNFSF15/TNFSF8 Variants and Leprosy Type 1 Reaction.Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations.The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylationStudying human immunodeficiencies in humans: advances in fundamental concepts and therapeutic interventions.Genomics of Immune Diseases and New Therapies.Learning from other diseases: protection and pathology in chronic fungal infections.Primary Immunodeficiency Diseases in Highly Consanguineous Populations from Middle East and North Africa: Epidemiology, Diagnosis, and Care.Regulation of RORγt in Inflammatory Lymphoid Cell Differentiation.Innate lymphoid cells in secondary lymphoid organs.Antifungal Immunological Defenses in Newborns.MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis.
P2860
Q26775891-FB62133D-81C4-457D-8D70-B2E7C6C76CEFQ26798127-DD5EBEB6-3921-4211-B9A3-62E0E19C48B9Q28070339-3BE5331A-43F7-4474-906C-AB6CD80FCDA3Q30238551-A36665AA-D73C-444E-B8AC-5BD526477EC2Q33752362-A8032BBE-362C-4F6F-9937-BFBC4BA9427FQ33887115-ECADF92C-04B5-4AFD-93B8-F0687C3A0032Q34540327-55545E70-5D81-4456-9AC2-84B38F5AF456Q35847333-2A2E2D9D-7559-4708-84C6-C3C86D765DF8Q35914364-E857B2B1-37D8-41F6-A48A-BDDE2F32F117Q36074922-73391EE5-10F0-47B5-8457-D217445C8DF1Q36250559-94B55766-E908-4572-83A8-F4B80DCF7D77Q36264301-3007D716-9F5B-44EA-A4E8-E74B3B218549Q36364264-5D1491B3-FEA6-465D-BEA1-6A4951090F40Q36409380-A850DEE6-7B65-486D-A939-8C438835B0CEQ36654943-869ACE8A-C7BD-4504-905B-3028E5C28E8FQ36684441-9AC5E1C3-214B-41CB-BB6F-B45B7D27B31AQ36767462-D9EFC122-F53F-45FF-9F68-900F5ED2D3BCQ36907762-318C5A46-C093-46FC-9AAE-F033C0F802CCQ37062344-7BA1E052-C984-429A-BD97-7019D2FA37E4Q37111268-199C5B2E-3B32-43C0-AA35-6BAB12B88F96Q37145726-F51D9464-0CC3-43BB-8E69-FC8CEBF2DB79Q37178987-7BE50B56-68FC-4B49-ACEA-D666B77A12D8Q37250132-3F131476-E229-4E63-BBDF-7753FDD29137Q37346692-29B50965-AA67-456A-A342-8E8D6823D4CDQ37393625-5250CF6D-ECBF-45E4-B2FA-4A7281D912A3Q37420149-39A96018-3507-48FA-B8FD-219097CA1826Q37534176-6A0EE219-F4B0-4A91-9A74-E07905B7DAC0Q37538514-5980DE0E-4546-4D2E-909F-FA4434C97930Q37639813-3A20853E-A043-4B71-8C12-1EC9D28CE644Q37677422-29ABF10A-0B73-4112-B4B1-9A104FF861C0Q37702568-A6601611-2B3A-4BEE-BEAF-C3722CE97347Q37730201-9E1C31D4-BA59-4165-A234-82040A01674AQ38560780-FD08A07A-5D7E-4599-8F7A-278265A3CB8FQ38588803-A5DAF56D-0EC1-4B71-9D00-90E200041D13Q38685163-AFEF520E-CB99-4E9E-B6B1-E69660485893Q38770481-9ABE10D5-D6B1-421A-8F7B-C70B6B02DF7CQ38810910-5CD84236-BD9F-424B-9F10-8314260AB757Q38865776-082FB3D0-9BAC-4335-9470-99A387F8F1ECQ38869734-5BAD559A-FBED-4CFB-A6C5-DAEBDD34A2ABQ38872144-222C69DB-ADA4-49C2-BE70-513CBD76F21E
P2860
IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
IMMUNODEFICIENCIES. Impairment ...... ith bi-allelic RORC mutations.
@ast
IMMUNODEFICIENCIES. Impairment ...... ith bi-allelic RORC mutations.
@en
type
label
IMMUNODEFICIENCIES. Impairment ...... ith bi-allelic RORC mutations.
@ast
IMMUNODEFICIENCIES. Impairment ...... ith bi-allelic RORC mutations.
@en
prefLabel
IMMUNODEFICIENCIES. Impairment ...... ith bi-allelic RORC mutations.
@ast
IMMUNODEFICIENCIES. Impairment ...... ith bi-allelic RORC mutations.
@en
P2093
P2860
P50
P356
P1433
P1476
IMMUNODEFICIENCIES. Impairment ...... ith bi-allelic RORC mutations.
@en
P2093
Aziz Belkadi
Chizuru Okada
Dan Engelhard
Danielle T Avery
Dina Averbuch
Elissa K Deenick
Federico Mele
Hiyam Marzouqa
Jamal Shamma
Jean-Pierre de Villartay
P2860
P304
P356
10.1126/SCIENCE.AAA4282
P407
P50
P577
2015-07-09T00:00:00Z